This weekend, Cal men’s swim and dive traveled to USC and UCSD to take care of business, competing and dominating in three competitions within a two day span.
Factor Bioscience to Deliver Six Digital Presentations at the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting
-The presentations will reveal advances in mRNA, circleRNA, gene editing, cell reprogramming, and iPS cell-derived NK-cell technologies.
- Factor s participation in this year s ASGCT Annual Meeting marks the company s ten-year anniversary and represents the most comprehensive presentation of the company s data to date.
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., May 11, 2021 /PRNewswire/ Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting to be held virtually May 11-14, 2021, at which Factor will deliver six digital presentations: